{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:33:21Z","timestamp":1758040401603,"version":"3.44.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100022513","name":"Tasmanian Department of Health","doi-asserted-by":"publisher","award":["JDRF-02"],"award-info":[{"award-number":["JDRF-02"]}],"id":[{"id":"10.13039\/501100022513","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008614","name":"Wesley Medical Research Ltd","doi-asserted-by":"publisher","award":["2016-56"],"award-info":[{"award-number":["2016-56"]}],"id":[{"id":"10.13039\/100008614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011334","name":"Health Innovation, Investment and Research Office","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011890","name":"Wesley Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011890","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.amjcard.2023.08.100","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T12:59:00Z","timestamp":1695733140000},"page":"260-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Hemostatic Profiles of Patients Who Underwent Transcatheter Versus Surgical Aortic Valve Replacement Versus Percutaneous Coronary Intervention"],"prefix":"10.1016","volume":"207","author":[{"given":"Jonathon Paul","family":"Fanning","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaun","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Anstey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Yerkovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence Yanxi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Poon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Incani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarvesh","family":"Natani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Winearls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Francis","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2023.08.100_bib0001","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","article-title":"Burden of valvular heart diseases: a population-based study","volume":"368","author":"Nkomo","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2023.08.100_bib0002","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.jacc.2019.08.1032","article-title":"Thrombotic versus bleeding risk after transcatheter aortic valve replacement: JACC review topic of the week","volume":"74","author":"Mangieri","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.08.100_bib0003","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2023.08.100_bib0004","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jacc.2012.01.001","article-title":"2012 ACCF\/AATS\/SCAI\/STS expert consensus document on transcatheter aortic valve replacement","volume":"59","author":"Holmes","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.08.100_bib0005","first-page":"1437","article-title":"2019 Canadian Cardiovascular Society position statement for transcatheter aortic valve implantation","volume":"35","author":"Asgar","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.amjcard.2023.08.100_bib0006","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jacc.2017.04.056","article-title":"Procedural experience for transcatheter aortic valve replacement and relation to outcomes: the STS\/ACC TVT registry","volume":"70","author":"Carroll","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.08.100_bib0007","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1161\/CIRCINTERVENTIONS.112.000170","article-title":"Incidence and clinical impact of stroke complicating percutaneous coronary intervention: results of the EURO heart survey percutaneous coronary interventions registry","volume":"6","author":"Werner","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2023.08.100_bib0008","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/eurheartj\/ehv113","article-title":"Stroke following percutaneous coronary intervention: type-specific incidence, outcomes and determinants seen by the British Cardiovascular Intervention Society 2007\u201312","volume":"36","author":"Kwok","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2023.08.100_bib0009","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.4244\/EIJ-D-20-00743","article-title":"Spontaneous echo contrast, left atrial appendage thrombus and stroke in patients undergoing transcatheter aortic valve implantation","volume":"16","author":"Linder","year":"2021","journal-title":"EuroIntervention"},{"key":"10.1016\/j.amjcard.2023.08.100_bib0010","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001565","article-title":"Evaluation of latest viscoelastic coagulation assays in the transcatheter aortic valve implantation setting","volume":"8","author":"Fanning","year":"2021","journal-title":"Open Heart"},{"key":"10.1016\/j.amjcard.2023.08.100_bib0011","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"Von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2023.08.100_bib0012","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12872-018-0976-0","article-title":"Simplification and optimization of transcatheter aortic valve implantation-fast-track course without compromising safety and efficacy","volume":"18","author":"Chopra","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.amjcard.2023.08.100_bib0013","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jacc.2012.09.001","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research consortium-2 consensus document","volume":"60","author":"Kappetein","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.08.100_bib0014","unstructured":"Horowitz GL, Altaie S, Boyd JC. Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline. CLSI. Available at: https:\/\/clsi.org\/media\/1421\/ep28a3c_sample.pdf. Accessed on: January 9, 2016."},{"year":"2015","series-title":"ROTEM sigma whole blood haemostasis system using thromboelastometry operating manual","key":"10.1016\/j.amjcard.2023.08.100_bib0015"},{"year":"2015","series-title":"TEG6s User Manual","author":"Haemonetics","key":"10.1016\/j.amjcard.2023.08.100_bib0016"},{"year":"2016","series-title":"Multiplate analyzer operator\u2019s manual","author":"Roche Diagnostics","key":"10.1016\/j.amjcard.2023.08.100_bib0017"},{"key":"10.1016\/j.amjcard.2023.08.100_bib0018","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.injury.2012.11.016","article-title":"Evaluation of TEG\u00ae and RoTEM\u00ae inter-changeability in trauma patients","volume":"44","author":"Hagemo","year":"2013","journal-title":"Injury"},{"key":"10.1016\/j.amjcard.2023.08.100_bib0019","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2307\/1164825","article-title":"Applied statistics for the behavioral sciences","volume":"15","author":"Hinkle","year":"1990","journal-title":"J Educ Behav Stat"},{"key":"10.1016\/j.amjcard.2023.08.100_bib0020","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s11239-011-0628-z","article-title":"Plasma fibrinogen levels and restenosis after primary percutaneous coronary intervention","volume":"33","author":"Lupi","year":"2012","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.amjcard.2023.08.100_bib0021","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/jth.12122","article-title":"Impaired fibrinolysis is associated with the severity of aortic stenosis in humans","volume":"11","author":"Natorska","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.amjcard.2023.08.100_bib0022","doi-asserted-by":"crossref","first-page":"796","DOI":"10.33963\/KP.a2021.0005","article-title":"Patients scheduled for TAVI tend to form abnormal fibrin clots more resistant to lysis: the impact of age","volume":"79","author":"Jaworska-Wilczy\u0144ska","year":"2021","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.amjcard.2023.08.100_bib0023","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1056\/NEJMoa022831","article-title":"Acquired von Willebrand syndrome in aortic stenosis","volume":"349","author":"Vincentelli","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2023.08.100_bib0024","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/01.CIR.103.7.961","article-title":"Defining the optimal activated clotting time during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials","volume":"103","author":"Chew","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2023.08.100_bib0025","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1053\/j.jvca.2010.11.020","article-title":"Are the point-of-care diagnostics MULTIPLATE and ROTEM valid in the setting of high concentrations of heparin and its reversal with protamine?","volume":"25","author":"Gertler","year":"2011","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.amjcard.2023.08.100_bib0026","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1055\/s-0038-1650647","article-title":"Depletion of intravascular pools of tissue factor pathway inhibitor (TFPI) during repeated or continuous intravenous infusion of heparin in man","volume":"76","author":"Hansen","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjcard.2023.08.100_bib0027","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/EJA.0b013e328363171a","article-title":"Validation of rotational thromboelastometry during cardiopulmonary bypass: A prospective, observational in-vivo study","volume":"31","author":"Gronchi","year":"2014","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.amjcard.2023.08.100_bib0028","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1111\/j.1537-2995.2008.01827.x","article-title":"Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: A prospective observational study","volume":"48","author":"Karlsson","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.amjcard.2023.08.100_bib0029","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ajh.23599","article-title":"TEG and ROTEM: technology and clinical applications","volume":"89","author":"Whiting","year":"2014","journal-title":"Am J Hematol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914923008652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914923008652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:49:49Z","timestamp":1757573389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914923008652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":29,"alternative-id":["S0002914923008652"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.08.100","relation":{},"ISSN":["0002-9149"],"issn-type":[{"type":"print","value":"0002-9149"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemostatic Profiles of Patients Who Underwent Transcatheter Versus Surgical Aortic Valve Replacement Versus Percutaneous Coronary Intervention","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.08.100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2023 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}